Clinical Trial Update: Digoxin for Recurrent Prostate Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports a completed Phase 2 study evaluating digoxin for recurrent prostate cancer, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DIGOXIN (Digoxin)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-06-05